[The management of myelocytic leukemia using dibrommannitol].
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001792:Blood Platelets; D004906:Erythrocyte Count; D006801:Humans; D007263:Infusions, Parenteral; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D000970:Antineoplastic Agents
Die Behandlung der Myelocytenleukämien mit Dibrommannitol.